Market Access Supply chains and the importance of transparency The pandemic revealed that global supply chains for the pharma industry are more fragile than expected.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face
